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partially responsible for the hemostatic activation,Abstract
it did not correlate with markers of endothelial
activation in patients with sepsis.  1999 ElsevierSepsis is commonly associated with disturbances of
Science Ltd. All rights reserved.the hemostatic balance. Most of the pathophysio-
logical changes in sepsis are caused by endotoxin
Key Words: Sepsis; Hemostasis; Endothelial damage; Cy-acting directly through endothelial injury or indi-
tokinesrectly through release of cytokines with procoagu-
lant effects. The relation between cytokines and he-
mostatic parameters was assessed in 32 patients with Sepsis is defined as a systemic inflammatorysepsis. Prothrombin fragment 112 (F112), throm- response to infection associated with the ac-bin-antithrombin III complexes (TAT), tissue type tivation of a number of host defense mecha-
plasminogen activator (t-PA) functional and antigen, nisms including the cytokine network, leukocytes
plasminogen activator inhibitor-1 (PAI-1), plasmin- and the hemostatic system [1]. Disseminated intra-
a2-antiplasmin complexes (PAP), D-Dimer, throm- vascular coagulation (DIC), with widespread depo-
bomodulin (TM) and von Willebrand factor (vWF) sition of fibrin in the microvasculature, is com-
were measured in patients and in 30 healthy subjects. monly found in septic shock and is linked closely
The levels of cytokines TNF-a and interleukin-6 to the development of multiple organ failure [2,3].
(IL-6) also were determined. A significant increase Endotoxin and certain cytokines such as tumor
of F112, TAT, PAI-1, PAP, and D-Dimer was necrosis factor (TNF-a), interleukin 1 beta (IL-1b),
observed in septic patients as compared with con- IL-6, and IL-8 are potent inducers of the above
trols (p,0.0001), whereas t-PA activity was signifi- mentioned changes through important modifica-
cantly reduced (p,0.01). The markers of endo- tions in the surface properties of vascular endothe-
thelial cell activation TM, vWF, and t-PA antigen lium, which becomes thrombogenic [4–6]. The en-
also were elevated significantly as compared with dothelial activation/damage induced by endotoxin
the control group (p,0.01). Finally, we found a and cytokines initiates the coagulation cascade and
marked increase of TNF-a and IL-6 (p,0.0001). alter the balance between activators and inhibitors
Whereas the increase of cytokine levels could be of the fibrinolytic system, which favors fibrin depo-
sition [7,8]. However, a direct relationship between
the cytokine levels and the changes in markers of
Abbreviations: TAT, thrombin-antithrombin III complexes; t-PA,
hemostatic and endothelial cell activation has nottissue type plasminogen activator; PAI-1, plasminogen activator
inhibitor; TM, thrombomodulin; vWf, von Willebrand factor; IL-6, been proven. Moreover, different antiendotoxin
interleukin-6. and anticytokine strategies have not been useful
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The aim of this work was to analyze whether a D-Dimer levels were measured with an ELISA
assay (FibrinostiKa FbDP; Organon Teknika,correlation between the levels of cytokines and
markers of endothelial cell and hemostatic activa- Turnhout, Belgium) [15].
The following markers of endothelial activationtion is present in patients with sepsis.
were measured using ELISA assays: tissue type plas-
minogen activator antigen (t-PA Ag) (Tint-Elize
1. Patients and Methods t-PA; Biopool, Umea˚, Sweden) [16]. Thrombomo-
dulin (Asserachrom thrombomodulin; Diagnostica
1.1. Samples Stago, Asnie`res, France) [17]. von Willebrand fac-
tor (Asserachrom von Willebrand factor; Diagnos-
The study group was composed of 24 men and 8 tica-Stago) [18].
women with a mean age of 48615 years, all suffer- The levels of cytokines IL-6 and TNF-a were
ing from sepsis. An age-sex matched group of 30 determined using the ELISA Kits Coaliza IL-6 and
healthy subjects served as control. At the time of Coaliza TNF-a (Chromogenix) [19,20].
entry into the study patients presented the typical
clinical picture with two or more of the following 1.3. Statistical Analysis
signs: 1) clinical evidence of infection, 2) tachypnea
(respiratory rate greater than 20 breaths per mi- The mean values, median and standard error of
nute), 3) tachycardia (heart rate greater than 90 the mean (SEM) are reported. Values were tested
beats per minute), and 4) temperature abnormali- for the type of distribution using Kolmogorov-
ties (greater than 38.48C or less than 35.68C). Nei- Smirnov test. Statistical analysis was done with the
ther DIC (according to standard clinical and analyt- two-tail Mann-Whitney U test for comparison of
ical criteria) nor septic shock (blood pressure of median of unpaired data. Correlations were calcu-
,90 mm Hg) was present at the time of sampling. lated using Spearman’s rank test. A value of p,0.05
Blood samples were drawn within 24 hours of the was considered to be significant.
onset of sepsis, collected in siliconized vacutainer
tubes containing 0.13 M trisodium citrate and put
on ice until centrifugation at 30003g for 15 min- 2. Results
utes. Aliquots of platelet-poor plasma were stored
at 2708C. Thirty-two patients with sepsis were included in
Samples for t-PA determination were collected the study, of which 20 presented positive blood
in Stabilyte tubes (Biopool, Sweden) in order to cultures. Sepsis was due to Gram negative bacteria
avoid inhibitors interferences. in 14 patients (43.7%). Gram positive organisms
were detected in five patients (15.6%), and fungal
infection was present in 1 patient (3.1%). The re-1.2. Assays
maining 12 patients presented a localized site of
infection (Staphylococcus aureus and epidermidisThe following hemostatic markers were included:
and Escherichia coli) and negative blood cultures.prothrombin fragment 112 (F112) and thrombin-
Tables 1 and 2 show the mean values of hemo-antithrombin III complexes (TAT) were assayed
static and endothelial cell activation markers. Corre-using commercial ELISA kits (EnzygnostR F112
lations between the different parameters are shownand EnzygnostR TAT, Berhingwerke AG, Ger-
in Table 3.many) [10,11]. Tissue type plasminogen activator
(t-PA) activity was determined by using a bio-
immunoassay (Coatest BIA tPA; Chromogenix, 2.1. Clotting Activation Markers
Mo¨lndal, Sweden) [12]. Plasminogen activator in-
hibitor (PAI-1) activity was measured by an ami- The markers of activation of the coagulation mech-
dolytic assay (Coatest PAI; Chromogenix) [13]. anism, F112 and TAT, were significantly elevated
Plasmin-a2-antiplasmin complexes (PAP) were in patients with sepsis as compared with the control
measured with an ELISA assay previously de- group (p,0.0001), indicating an important degree
of prothrombin activation and thrombin genera-scribed in our laboratory by Montes et al. [14].
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Table 1. Hemostatic parameters in patients with sepsis and controls
Sepsis Control p
F112 (nmol/l) 2.0860.18 (1.89) 1.0260.11 (1.00) ,0.0001
TAT (ng/ml) 14.0561.75 (12.00) 1.6660.05 (1.60) ,0.0001
t-PA activity (U/ml) 0.1760.03 (0.14) 0.2760.02 (0.24) 50.003
PAI-1 activity (U/ml) 23.6262.04 (23.00) 8.9360.93 (8.00) ,0.0001
PAP (ng/ml) 1982.496382.47 (1446.50) 573.506125.10 (530.00) ,0.0001
D-Dimer (ng/ml) 3641.336749.15 (2200.00) 240.6767.78 (260.00) ,0.0001
Mean values 6SEM (median) are indicated.
tion (Table 1). A positive correlation between both p50.02) and negatively with t-PA activity (r5
markers was observed (r50.54, p,0.01) (Table 3). 20.66, p50.001). Finally, we found correlations of
t-PA Ag with PAI-1 activity (r50.58, p50.001) and
negatively with t-PA activity (r520.52, p50.009).2.2. Fibrinolytic Components
No differences in any of the hemostatic parame-
As regards fibrinolytic parameters we found a signifi- ters and endothelial cell markers were observed in
cant increase of PAI-1, PAP, and D-Dimer (p, Gram negative as compared with Gram positive
0.0001). Conversely, a marked decrease of t-PA activ- sepsis (data not shown).
ity (p50.003) was observed in the patients group as
compared to controls (Table 1). We also observed a
2.4. Cytokinesnegative correlation between t-PA activity and PAI-1
(r520.77, p,0.0001) and positive between PAP and
The plasma concentration of TNF-a and IL-6 wereD-Dimer (r50.48, p,0.05) (Table 3).
assessed in all patients and controls (Table 2). We
observed a marked increase of both cytokines in the2.3. Markers of Endothelial Cell Activation
group of patients (p,0.0001), being the elevation of
IL-6 five times higher than the increase of TNF-aThrombomodulin, t-PA antigen and von Wille-
with respect to the values observed in controls.brand factor are released after endothelial pertur-
We also assessed the correlations between thesebation. A significant increase of these parameters
cytokines and the different parameters analyzedwas observed in patients as compared with controls
(Table 3). A positive correlation between TAT(p,0.005), with maximum differences for t-PA and
levels with both TNF-a (r50.39, p50.04) and IL-6vWF (p,0.0001), indicating an important degree of
(r50.64, p,0.01) could be demonstrated. IL-6 alsoendothelial activation in septic patients (Table 2).
correlated with D-Dimer (r50.42, p,0.01) andAs shown in Table 3, the following correlations
PAI-1 activity (r50.58, p,0.001). No significantwere observed: vWF correlated positively with t-PA
correlations of cytokines with the markers of endo-Ag (r50.50, p50.007) and TM (r50.53, p50.004).
TM also correlated significantly with PAI-1 (r50.43, thelial activation were observed.
Table 2. Markers of endothelial activation and cytokine levels in patients with sepsis
and controls
Sepsis Control p
TM (ng/ml) 102.47614.88 (56.80) 37.3663.14 (37.20) 50.005
vWF (%) 406.27630.95 (412.50) 101.4469.59 (99.00) ,0.0001
t-PA Ag (ng/ml) 23.6363.04 (20.00) 4.7660.37 (5.00) ,0.0001
TNF-a (pg/ml) 73.61612.11 (70.00) 5.7160.69 (5.00) ,0.0001
IL-6 (pg/ml) 186.35634.33 (103.00) 3.1260.65 (5.00) ,0.0001
Mean values 6SEM (median) are indicated.
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3. Discussion
It is known that most of the pathophysiological
changes in sepsis are caused by endotoxin acting
directly through endothelial injury or indirectly
through release of mediators, such as TNF and
cytokines, which also affect the endothelial cell
function triggering procoagulant and antifibrino-
lytic effects [4,5,21,22]. The current study was un-
dertaken to determine whether the plasma levels
of some markers of hemostatic and endothelial cell
activation correlate with the cytokine levels in a
series of patients with sepsis.
A significant increase of F112 and TAT was
observed in patients with respect to controls, indi-
cating a marked clotting activation, similar to that
observed after intravenous administration of endo-
toxin to human subjects [4], probably reflecting
activation of the extrinsic pathway as assessed by
in vivo studies using monoclonal antibodies to TF
and factor VII [23–25].
As regards fibrinolysis, we found a significant
increase of PAI-1 activity, PAP, and D-Dimer, as
well as a decrease of t-PA activity in patients with
respect to controls. The fibrinolytic system seems
to play an important pathologic role in sepsis and
may contribute to the appearance of microthrombi
[26–28]. Several studies have reported that, after
endotoxemia and cytokinemia, the fibrinolytic sys-
tem becomes initially activated and subsequently
inhibited [4,22,28]. The injection of TNF-a or endo-
toxin to humans is initially followed by a strong
increase in plasminogen activator activity, which
results in the conversion of plasminogen to plas-
min, as reflected by the enhanced levels of PAP
observed in our series of septic patients. Later,
the increased PAI-1 neutralizes t-PA, although the
fibrinolytic system still remains functionally active
as demonstrated by the generation of D-Dimer.
An association of PAI-1 levels with mortality in
DIC due to sepsis has also been shown [29].
The lack of differences in the parameters analyzed
in relation to blood cultures could be due to the
reduced sample analyzed, although it is also known
that the hemostatic activation is not always associated
with the plasma endotoxin concentrations [4,26].
In a further step, we analyzed several markers
of endothelial cell activation, since vascular endo-
thelium plays an important role in the regulation ofTa
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the hemostatic balance in sepsis [7,30]. The plasma
99Y. Lo´pez-Aguirre et al./Thrombosis Research 94 (1999) 95–101
levels of vWF, TM, and tPA were markedly ele- References
vated, indicating a marked endothelial activation
[30–32]. The observed correlations between TM 1. American College of Chest Physicians/Society
with both TAT and t-PA activity would indicate of Critical Care Medicine Consensus Confer-
that endothelial perturbation contributes to the ence. Definitions for sepsis and organ failure
clotting and fibrinolysis activation in sepsis. and guidelines for the use of innovative thera-
Laboratory and clinical evidence indicates that the pies in sepsis. Crit Care Med 1992;20:864–74.
toxic effects of endotoxin are mediated by cytokines, 2. Glauser MP, Zanetti G, Baumgartner JD, Co-
some of which were detected in significant amounts hen J. Septic shock: Pathogenesis. Lancet 1991;
in our series of septic patients, confirming previous 338:732–6.
reports [20,33,34]. To demonstrate whether the cyto- 3. Levi M, ten Cate H, van der Poll T, van De-
kine increase was responsible for some of the ob- venter SJH. Pathogenesis of disseminated in-
served changes, we analyzed their correlations with travascular coagulation in sepsis. JAMA 1993;
markers of endothelial and hemostatic activation. A 270:975–9.
significant correlation was found between cytokines 4. van Deventer SJH, Buller HR, ten Cate JW,
and hemostatic activation markers, suggesting that Aarden LA, Hack CE, Sturk A. Experimental
inflammatory mediators directly contribute to both endotoxemia in humans: Analysis of cytokine
thrombin and plasmin generation in human sepsis, release and coagulation, fibrinolytic, and com-
which agrees with in vivo studies after administration plement pathways. Blood 1990;76:2520–6.
of endotoxin to healthy subjects [6], as well as experi- 5. Nawroth PP, Stern DM. Modulation of endo-
mental studies using specific monoclonal antibodies thelial cell hemostatic properties by tumor ne-
against TNF and IL-6 [35–37]. crosis factor. J Exp Med 1986;163:740–5.
The lack of correlations between cytokines and 6. Nawroth PP, Handley DA, Esmon CT, Stern
markers of endothelial damage could be due to differ- DM. Interleukin 1 induces endothelial cell pro-
ences in in vivo half lives (e.g., 5 minutes for t-PA coagulant while supressing cell-surface antico-
and 12 hours for vWF), as well as to the fact that agulant activity. Proc Natl Acad Sci USA 1986;
cytokines exert effects at a distance from the site of 83:3460–4.
production. In addition, the mechanisms responsible 7. Pober JS, Cotran RS. Cytokines and endothe-
for the release of these markers from vascular endo- lial cell biology. Physiol Rev 1990;70:427–51.
thelial cells vary considerably [38,39]. Thus, absence 8. Schleef RR, Bevilacqua MP, Sawdey M, Gim-
of correlations does not neccesarily mean absence of brone MA, Loskutoff DJ. Cytokine activation
causality, since local effects cannot be excluded. On of vascular endothelium. Effects on tissue-type
the other hand, whether such a correlation would plasminogen activator and type 1 plasminogen
exist in severe sepsis accompanied by shock or DIC activator inhibitor. J Biol Chem 1988;263:5797–
has not been explored in the present study. 803.
In conclusion, during sepsis an important hemo- 9. Suffredini AF. Current prospects for the treat-
static activation takes place, indicated by a strong ment of clinical sepsis. Chest 1994;22:S12–8.
increase of F112 and TAT. The fibrinolytic system 10. Pelzer H, Schwarz A, Stuber W. Determination
remains functionally active in spite of the enhanced of human prothrombin activation fragment 112
PAI-1 activity. We also found a marked increase in plasma with an antibody against a synthetic
of TM, vWF and t-PA Ag, indicating an important peptide. Thromb Haemostas 1991;65:153–9.
degree of endothelial cell activation, and a significant 11. Pelzer H, Schwarz A, Heimburger N. Determi-
increase of circulating cytokines TNF-a and IL-6. nation of human thrombin-antithrombin com-
The lack of correlation between cytokine levels and plex in plasma with an enzyme-linked immu-
endothelial cell markers does not exclude a pathoge- nosorbent assay. Thromb Haemostas 1988;59:
netic role of cytokines in the endothelial cell pertur- 101–6.
bation present in human sepsis. 12. Mahmoud M, Gaffney PJ. Bioimmunoassay
(BIA) of tissue plasminogen activator (t-PA)
Supported by grant 92/0191 from FIS of the Ministery of Health, and its specific inhibitor (t-PA/INH). Thromb
Spain. Haemostas 1985;53:356–9.
100 Y. Lo´pez-Aguirre et al./Thrombosis Research 94 (1999) 95–101
13. Chmielewska J, Ranby M, Wiman B. Evidence inhibition of endotoxin-induced activation in
chimpanzees with a monoclonal Fab fragmentfor a rapid inhibitor to tissue plasminogen acti-
vator in plasma. Thromb Res 1983;31:427–36. against factor VII/VIIa. Thromb Hemost 1995;
73:223–30.14. Montes R, Pa´ramo JA, Angle´s-Cano E, Rocha
E. Development and clinical application of a 24. Taylor FB Jr , Chang A, Ruf W, Morrissey JH,
Hinshaw L, Catlett R, Blick K, Edgington TS.new ELISA assay to determine plasmin-a2
antiplasmin complexes in plasma. Br J Haema- Lethal E. coli septic shock is prevented by
blocking tissue factor with monoclonal anti-tol 1996;92:979–85.
15. Koppert PW, Hoegee-de Nobel E, Nieuwen- body. Circ Shock 1991;33:127–34.
25. Levi M, ten Cate H, Bauer KA, van der Pollhuizen W. A monoclonal antibody-based en-
zyme immunoassay for fibrin degradation prod- T, Edgington TS, Buller HR, van Deventer J,
Hack CE, ten Cate JW, Rosenberg RD. Inhibi-ucts. Thromb Haemostas 1988;59:310–5.
16. Bergsdorf N, Nilsson T, Wallen P. An enzyme tion of endotoxin-induced activation of coagu-
lation and fibrinolysis by pentoxifylline or bylinked immunosorbent assay for determination
of tissue plasminogen activator applied to pa- monoclonal anti-tissue factor antibody in chi-
mapanzees. J Clin Invest 1994;93:114–20.tients with thromboembolic disease. Thromb
Haemostas 1983;50:740–4. 26. Colucci C, Pa´ramo JA, Collen D. Generation
in plasma of a fast-acting inhibitor of plasmino-17. Maruyama I, Bell C, Majerus PW. Thrombo-
modulin found on endothelium of arteries, gen activator in response to endotoxin stimula-
tion. J Clin Invest 1985;75:818–24.veins capillaries, and lymphatics, and on syn-
cytiotriophoblast of human placenta. J Cell 27. Pa´ramo JA, Pe´rez JL, Serrano M, Rocha E.
Types 1 and 2 plasminogen activator inhibitorBiol 1985;101:363–8.
18. Ness PM, Perkins HA. A simple enzyme-im- and tumor necrosis factor alpha in patients with
sepsis. Thromb Haemost 1990;64:3–6.munoassay (EIA) test for factor VIII-related
antigen (VIIIAGN). Throm Haemost 1979; 28. Suffredini AF, Harpel PC, Parrillo JE. Promo-
tion and subsequent inhibition of plasminogen42:848–57.
19. Helle M, Boeije L, de Groot E, de Vos A, activator after administration of intravenous
endotoxin to normal subjects. N Engl J MedAarden L. Sensitive ELISA for interleukin-6.
Detection of IL-6 in biological fluids: Synovial 1989;320:1165–72.
29. Pralong G, Kalandra T, Glauser MP, Schellek-fluids and sera. J Immunol Methods 1991;
138:47–56. ens J, Verhoef J, Bachmann F, Kruithof EKO.
Plasminogen activator inhibitor 1: A new prog-20. Girardin E, Grau GE, Dayer JM, Roux-Lom-
bard P, Lambert PH. Tumor necrosis factor nostic marker in septic shock. Thromb Hae-
most 1989;61:459–62.and interleukin-1 in the serum of children with
severe infectious purpura. N Engl J Med 1988; 30. Wada H, Minamikawa K, Wakita Y, Nakase T,
Kaneko T, Ohiwa M, Tamaki S, Deguchi K,319:397–400.
21. van der Poll T, Buller HR, ten Cate H, Wortell Shirakawa S, Hayashi T. Increased vascular en-
dothelial cell markers in patients with dissemin-CH, Bauer KA, van Deventer SJH, Hack CE,
Sauerwein HP, Rosenberg RD, ten Cate JW. ated intravascular coagulation. Am J Hematol
1993;44:85–8.Activation of coagulation after administration
of tumor necrosis factor to normal subjects. N 31. Uchiyama H, Hiraischi S, Ohtani H, Ishii H,
Kazama M. Plasma thrombomodulin is origi-Engl J Med 1990;322:1622–7.
22. van der Poll T, Levi M, Buller HR, van De- nated by damage of endothelial cells. Thromb
Haemost 1989;62:276–82.venter SJH, de Boer JP, Hack CE, ten Cate
JW. Fibrinolytic response to tumor necrosis 32. Giddings JC, Coles P, Williams BD. Compari-
son of thrombomodulin and von Willebrandfactor in healthy subjects. J Exp Med 1991;
174:729–32. factor antigen in human plasma in various dis-
ease. Thromb Haemost 1989;62:233–8.23. Biemond BJ, Levi M, ten Cate H, Soule HR,
Morris LD, Foster DL, Bogowitz CA, van der 33. Hack CE, De Groot ER, Felt-Bersma RJ, Nui-
jens JH, Strack van Schijndel RJ, Eerenberg-Poll T, Buller HR, ten Cate JW. Complete
101Y. Lo´pez-Aguirre et al./Thrombosis Research 94 (1999) 95–101
Belmer AJ, Thijs Lg, Aarden LA. Increased Cate H, Haagman BL, Biemond BJ, Buller
HR, Hack CE, ten Cate JW. Differential ef-plasma levels of interleukin-6 in sepsis. Blood
fects of anti-tumor necrosis factor monoclonal1989;74:1704–10.
antibodies on systemic inflammatory responses34. Michie HR, Manogue KR, Spriggs DR, Re-
in experimental endotoxemia in chimpanzees.vhaug A, O’Dwyer S, Dinarello CA, Cerami A.
Blood 1994;83:446–51.Detection of circulating tumor necrosis factor
37. van der Poll T, Levi M, Hack CE, ten Cate H,after endotoxin administration. N Engl J Med
van Deventer SJ, Eerenberg AJ, de Groot ER,1988;318:1481–6.
Jansen J, Gallati H, Buller HR, ten Cate JW,35. Biemond BJ, Levi M, ten-Cate H, van der Poll Aarden LA. Elimination of interleukin 6 atten-
T, Buller HR, Hack CE, ten Cate JW. Plasmin- uates coagulation activation in experimental
ogen activator and plasminogen activator in- endotoxemia in chimpanzees. J Exp Med 1994;
hibitor I release during experimental endotox- 179:1253–9.
aemia in chimpanzees: Effect of interventions 38. Hack CE, Aarden LA, Thijs LG. Role of cyto-
in the cytokine and coagulation cascades. Clin kines in sepsis. Adv Immunol 1997;66:101–95.
Sci Colch 1995;88:587–94. 39. Schlag G, Redl H. Mediators of injury and
inflammation. World J Surg 1996;20:406–10.36. van der Poll T, Levi M, van Deventer SJ, ten-
